Senior Clinical Research Manager and CRO Lead

15 years of experience in the set-up and delivery of mental healthcare research with leadership roles in large research programmes at the National Institute for Health Research (NIHR) and University of Cambridge.

Therapy Lead

Former Head of Therapy Research and Training at COMPASS and Chief Clinical Officer at ieso Digital Health. Sarah has delivered over 30,000 hours of therapy and acted as Principal Investigator in trials.

Clinical Director

Senior doctor, worked in public health services in the UK and Ireland for over 20 years. Honorary Senior Lecturer at The University of Oxford with past 10 years as Consultant Psychiatrist at Oxford University Hospital NHS Foundations Trust.

Chief Investigator

20 years' experience in lab-based psychopharmacology and psychiatry. Honorary Clinical Senior Lecturer at King’s College London.​ Designed and coordinated numerous cannabinoid and ketamine trials with over 200 participants

Clinical Operations Director

14 years of experience leading clinical operations in private SMOs. Experience in leading cross-functional medical teams and leading implementations of new processes including enhanced protocol adherence, vendor set-up, patient recruitment, and licensing.

Clinical Research Physician

Medical doctor and neuroscience graduate from Cambridge University and UCL. Co-founder of UCL Society for the Application of Psychedelics. Previously a researcher in clinical trials in the field of neuropsychiatry in the NHS.

Therapist Coordinator

Psychedelic-assisted therapist alongside delivering a private therapy practice. Background in Rogerian counselling and evidence-based psychotherapy practices (ACT and DBT), across a range of settings from charities, schools, and the NHS.

Clinical Trials Assistant

MSc Psychological Therapies graduate from Queen Mary University. Previously worked as Head of Research at NHS Early Intervention in Psychosis Service, with clinical experience at Islington Mind.

Clinical Admin

PhD student at the Centre for Psychedelic Research at Imperial College London and an MSc in Clinical Neuroscience from King's College London. Background in molecular neuroscience with 2 years of experience in clinical research.

Research Nurse

14 years of experience as a nurse in the fields of Alzheimer’s and Dementia including 6 years of research experience in emergency departments.

Clinical Admin and Pharmacy Dispenser

BSc Forensic Science graduate with several years of experience as a scientist processing samples in biotechnology research companies including hVIVO.

Clinical Trial Pharmacist​

GPhC registered pharmacist with over 5 years' experience working within the NHS, specialising in Neurosciences and Clinical Trials. ​

Patient Recruitment Manager

BSc Experimental Psychology graduate from the University of Bristol,. Previously worked as an editor and manager for the Advanced Therapies Congress, specialising in Cell and Gene Therapies.

Site Coordinator

Yale and UCL neuroscience and psychopathology research master's graduate. Specialised in ketamine trials for adolescent treatment-resistant depression, suicidality, and eating pathologies before transitioning to the role of Site Coordinator at Clerkenwell Health.

Patient Engagement Lead

Psychology with Counselling student at the University of Greenwich, president of the Greenwich Psychedelic Society, a member of the Psilocybin Access Rights campaign.

Research Nurse

Qualified as a nurse in 2015 at the University of La Sapienza in Rome. Experience working in acute hospital settings in Kent and across multiple sites in London. Spent a year in clinical research at Imperial College with Phase II and III trials.

Chief Scientific Officer

Oxford PhD in CNS drug delivery. Started his career at the Beckley Foundation in 2015. Since then Henry has founded three companies in the psychedelics and cannabis sectors and advised clients on R&D strategies, IP generation and research operations. ​

Chief Executive Officer

Background in the biopharmaceutical sector including 18 months at IQVIA (formerly Quintilles-IMS, the world’s largest CRO) alongside experience across 5 of the global top 10 pharma companies.

Chief Financial Officer

FCCA qualified accountant with 10 years of restructuring, M&A strategy and commercial diligence for corporate clients at PwC’s Deals team in London and then as financial director at Hanway Associates.

Chief Commercial Officer

Commercial barrister turned drug policy reform advocate. Co-founded Hanway Associates, a strategic advisory firm working in the nascent European cannabis sector. Previously worked at Beckley Foundation and Volteface.

Corporate Communications and Marketing Analyst

Researcher in health and innovation systems, consulting European & Developing Countries Clinical Trials Partnership and Foreign, Commonwealth & Development Office. Co-founded NeuroSight, a drug harm reduction consultancy.

Corporate Analyst

Former start-up co-founder with a background in growth and operations in health tech and media. Philosophy, Politics and Economics graduate from the University of Oxford.

Therapy Programme Operations Manager

Double-MSc in Applied Neuroscience at King’ College London, and Innovation & Entrepreneurship at Esade Business School. Previously worked at two psychedelic venture capital firms, The Conscious Fund and Leafy Tunnel.

Financial Manager

Chartered Global Management Accountant with over 9 years experience in the field of Accounting and Finance. Over the years have served in leading Finance roles for Multinational and International companies.

Head of Quality

Over 30 years’ experience in Clinical Quality Assurance - working within Pfizer Ltd and GW Pharmaceuticals, before becoming a QA Consultant.

Quality Assurance Manager

Worked in academia and industry for a number of years as both a Quality Manager and bench scientist collecting and processing samples for cancer and neurological research and Clinical Trials.​

Quality Assurance Manager

8 years experience in clinical trials with over 4 years in participant recruitment and 3 years as a Quality Research Associate at one of Europe’s largest phase 1 units.

22 years at GSK, most recently as Therapeutic Director for CNS diseases. Co-founder of three drug discovery companies and board member of several others.

Clinical Director and Deputy Head of the Centre for Psychedelic Research at Imperial College London. Consultant Psychiatrist at CNWL Mental Health NHS Foundation Trust.

Associate Professor at University of Copenhagen and Copenhagen University Hospital. Honorary Clinical Research Fellow in Centre for Psychedelic Research at Imperial.

Associate Professor at Maastricht University, at the Faculty of Psychology and Neuroscience. PhD focused on memory and risk-taking during MDMA intoxication.

UK&I Head of Start-up Ventures and Open Innovation at Accenture. Over 10 years experience working across a range of digital strategy, analytics and technology transformation projects.

CEO and Founder of braincare company, Heights Braincare. Host of the UK's #1 business podcast, Secret Leaders.